This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Fund Appoints Mark Dybul As Executive Director

GENEVA, Nov. 15, 2012 /PRNewswire/ -- The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria today appointed as its new Executive Director Ambassador Mark R. Dybul, a former United States Global AIDS Coordinator.

Dr. Dybul is widely recognized as a visionary leader on global health for his role in helping create and then lead the President's Emergency Program for AIDS Relief, known as PEPFAR, which has been highly effective in helping limit and reverse the growth of HIV infection worldwide. Trained as a medical doctor with a specialty in immunology, he became an expert on AIDS as a clinician, a scientist and as a strategically minded administrator.

" Mark Dybul is a true leader, who can take the Global Fund to the next level," said Simon Bland, Board Chair of the Global Fund. "He has a really impressive vision of how to achieve global health goals. He is passionate, energetic and focused."

Dr. Dybul currently co-directs the Global Health Law Program at the O'Neill Institute for National and Global Health Law at Georgetown University, where he is also a Distinguished Scholar.  

" Mark Dybul is a dynamic and effective leader," said Mphu Ramatlapeng, former Health Minister of Lesotho and Board Vice-Chair of the Global Fund. "He brings real knowledge, strategic vision and a commitment to working with partners."  

Dr. Dybul may be best known for playing a key role in creating, and later leading, PEPFAR - the largest global health initiative ever undertaken to address a single disease, which is widely credited with helping reverse the trend of AIDS, reducing new infection in many countries.

He was serving as a staff clinician at the National Institute of Allergy and Infectious Diseases in Washington D.C. when he joined a task force that eventually led to the creation of PEPFAR. In 2004, he moved to PEPFAR full-time as Deputy Chief Medical Officer. He was soon promoted to Assistant, then Deputy and then Acting U.S. Global AIDS Coordinator. In 2006, he was appointed to head the organization as U.S. Global AIDS Coordinator, equivalent to the level of an Assistant Secretary of State in the U.S. State Department. He served until 2009.

Dr. Dybul also has deep knowledge of implementation of programs to treat and prevent AIDS, TB and malaria in developing countries, and has experience working with health administrators at many levels, especially in Africa.

In addition, he currently serves as a director on numerous executive and advisory boards of health organizations, including Malaria No More, the Elizabeth Glaser Pediatric AIDS Foundation, the Children's Investment Fund Foundation and the Global Business Coalition for Health.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs